Terje Espevik,Tom Eirik Mollnes,Inger Sandlie,Corinna Lau,Kristin S. Gunnarsen
申请号：
US15126938
公开号：
US20170107294A1
申请日:
2014.03.21
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to chimeric anti-CD14 antibodies and methods of using the same. In some embodiments, the present invention relates to the use of chimieric anti-CD 14 antibodies in research, diagnostic, and therapeutic applications. In one embodiment, the anti-CD14 antibody has a variable light chain of SEQ ID NO: 1 and a variable heavy chain of SEQ ID NO: 2 (isolated from the hybridoma clone 18D11). In another embodiment, the anti-CD14 antibody has a variable light chain of SEQ ID NO: 3 and a variable heavy chain of SEQ ID NO: 4 (isolated from the hybridoma clone Mil2).
